Basal thyrotropin and major depression: Relation to clinical variables and treatment outcome

Canadian Journal of Psychiatry

Volumn 53, Issue 12, 2008, Pages 833-838

  Joffe, Russell T ^a,c   Levitt, Anthony J ^b  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (United States)

Author keywords

Antidepressant; Major depressive disorder; Thyrotropin

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; THYROID HORMONE; THYROTROPIN; VENLAFAXINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EUTHYROIDISM; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; SUICIDE ATTEMPT; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 58149215903     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805301209     Document Type: Article

References (24)

1. Joffe RT. The thyroid and depression. In: Joffe RT, Levitt AJ, editors. The thyroid axis and psychiatric illness. Washington (DC): American Psychiatric Press; 1993. p 265-290.
2. Bauer MS, Whybrow PC. Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integr Psychiatry. 1988;6:75-81.
3. Christ-Crain M, Meier C, Roth C-B, et al. Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: disgnostic and therapeutic impact of assay performance. Eur J Clin Invest. 2002;32:931-937.
4. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
5. Hak AE, Pols HA, Visser, T, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132:270-278.
6. Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotrophin result: a 10 year cohort study. Lancet. 2001;358:861-865.
7. Joffe RT, Levitt AJ. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology. 1992;17:215-221.
8. Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry. 1993;54:47-54.
9. Duval F, Mokrani MC, Crocq MA, et al. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry. 1996;53:833-840.
10. Brouwer JP, Appelhof BC, Peeters RP, et al. Thyrotropin but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. Eur J Endocrinol. 2006;154:819-825.
11. Corruble E, Berlin I, Lemoine A, et al. Should major depression with "high normal" thyroid-stimulating hormone be treated preferentially with tricyclics? Neuropsychobiology. 2004;50:144-146.
12. Gitlin M, Altshuler LI, Frye MA, et al. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J Psychiatry Neurosci. 2003;29:383-386.
13. Maes M, Meltzer HY, Cosyns P, et al. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology. 1993;18:607-620.
14. Magliozzi JR, Maddock RJ, Gold AS, et al. Relationships between thyroid indices and symptoms of anxiety in depressed outpatients. Ann Clin Psychiatry. 1993;5:111-116.
15. Brabant G, Beck-Peccoz P, Jarzab B, et al. Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol. 2006;154:633-637.
16. Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid. 2005;15:1035-1039.
17. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005;90:5489-5496.
18. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90:5483-5488.
19. Spitzer RL, Endicott J, Robbins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35:773-782.
20. Spitzer RL, Endicott J. Schedule of Affective Disorders and Schizophrenia-Lifetime Version (SADS-L). New York (NY): New York State Psychiatric Institute, Biometrics Research; 1978.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
22. Vandoolaeghe E, Maes M, Vandevywere J, et al. Hypothalamic-pituitary- thyroid-axis function in treatment resistant depression. J Aff Dis. 1997;43:143-150.
23. Reus VI. Psychiatric aspects of thyroid disease. In: Joffe RT, Levitt AJ, editors. The thyroid axis and psychiatric illness. Washington (DC): American Psychiatric Press; 1993. p 57-83.
24. Spencer CA, Schwarzheim D, Guttler RB, et al. Thyrotropin (TSH)-releasing hormone stimulation testresponses employing third and fourth generation TSH assays. J Clin Endocrinol Metab. 1993;76:494-498.